Enterprise Metals Ltd Stock
Price
Target price
€0.001
€0.001
0.000%
-
0.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Enterprise Metals Ltd Stock
The Enterprise Metals Ltd price is unchanged compared to yesterday.
Pros and Cons of Enterprise Metals Ltd in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Enterprise Metals Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enterprise Metals Ltd | 0.000% | 0.000% | 0.000% | 0.000% | -50.000% | 0.000% | -85.714% |
| Strategic Energy Resources | -7.230% | 9.220% | -15.847% | 15300.000% | 15300.000% | 1611.111% | 227.660% |
| Black Ridge Mining Ltd | -3.850% | -7.407% | -7.407% | 2400.000% | 1150.000% | 108.333% | 92.308% |
| Elementos Ltd | -7.080% | -4.369% | 10.674% | 155.844% | 17.964% | 194.030% | -7.294% |
News
Audioeye Q2 Earnings Call Highlights
Key Points
- Interested in Audioeye, Inc.? Here are five stocks we like better.
- Revenue and recurring growth continued: AudioEye’s second-quarter revenue rose 9% year over year to $10.7 million
Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance
Cellebrite DI (NASDAQ:CLBT), a digital forensics and investigative intelligence software provider, closed at $10.80, down 29.18%. The stock tumbled after Cellebrite cut full-year revenue guidance
Docebo Targets Government, Healthcare and AI as Enterprise Momentum Builds
Key Points
- Interested in Docebo Inc.? Here are five stocks we like better.
- Docebo is expanding into government and healthcare, with its first full federal sales cycle underway after receiving